Log in to your Inderes Free account to see all free content on this page.
Enorama Pharma
0.39 SEK
-2.99 %
Less than 1K followers
ERMA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Enorama Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.5 | 2.6 | 15.8 | 0.5 | 0.7 | 1.8 | 2.7 | |
| EBITDA | -3.7 | -8.8 | -27.1 | -16.5 | -15.2 | -12.3 | -18.4 | -62.3 |
| EBIT | -4.5 | -26.7 | -47.5 | -16.7 | -15.3 | -12.3 | -18.5 | -62.8 |
| EBIT-% | -59.8 % | -1,017.9 % | -301.3 % | -3,706.7 % | -2,098.6 % | -1,055.5 % | -2,293.2 % | |
| Profit before taxes | -7.1 | -22.0 | -43.8 | -22.5 | 18.7 | -13.4 | -20.6 | -75.1 |
| Net income | -7.1 | -22.0 | -43.8 | -22.5 | -18.7 | -13.4 | -20.6 | -75.1 |
Login required
This content is only available for logged in users